Concepedia
Statistics
Publications
8
Citations
629
H-Index
Active since
1993
Affiliations
Pfizer (United States)(Current)
PRA Health Sciences
Sunovion (United States)
R.H. Swift is an author at Pfizer (United States) specializing in pharmacology, medicine, and psychopharmacology.
Publications per year
1993–2003
Intramuscular Ziprasidone, 2 mg Versus 10 mg, in the Short-Term Management of Agitated Psychotic Patients
Michael D. Lesem, John Zajecka, R.H. Swift et al. · The Journal of Clinical Psychiatry · 2001 · 220 citations
Medicine, Pharmacology, Psychiatry +17
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial
David G. Daniel, Steven G. Potkin, Karen R. Reeves et al. · Psychopharmacology · 2001 · 174 citations
Medicine, Pharmacology, Pharmacotherapy +14
Validation of the behavioural activity rating scale (BARS)™: a novel measure of activity in agitated patients
R.H. Swift, Edmund P. Harrigan, Joseph C. Cappelleri et al. · Journal of Psychiatric Research · 2002 · 146 citations
Education, Behavioral Sciences, Psychology +13
The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy
David G. Daniel, Dan Zimbroff, R.H. Swift et al. · International Clinical Psychopharmacology · 2003 · 35 citations
Medicine, Pharmacology, Pharmacotherapy +13
Ipecacuanha-induced emesis: A human model for testing antiemetic drug activity
Neil Minton, R.H. Swift, Caroline Lawlor et al. · Clinical Pharmacology & Therapeutics · 1993 · 22 citations
Medicine, Pharmacology, Pharmacotherapy +16
1–5 of 8